1 Ballantyne CM, Podet BJ, Patsch WP, et al.Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA, 1989,262:5 3
2 Ibels LS, Alfrey AC, Weil R.Hyper lipidemia in adult, pediatric, and diabetic renal transplant recipients. Am J Med, 1978, 64:634
3 Bagdade JD, Porte D, Bierman EL.Hypert rigly ceridemia:a metabolic consequence od chronicrenal failure.N Eng 1 J Med, 1968, 279:1436
4 Costanzo-Nordin M R, grady K L, Johnson M R, et al.LonG-term effects of cyclo sporine-based immunosuppression in cardiac transplanta tion:The Loy ola e xperience.Transplant Proc, 1990,22:6
5 Raine AEG, Ca rte r R, Mann JI, et al.Adve rse effects of cyclosporine on plasma cholesterol in renal transplant recipients.Nephrol Dial transplant, 1988, 3:458
6 Vathsala A, Weinberg RB, Schoenberg L, et al. Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients.transplantation, 1989, 48:3 7
7 Vathhsa la A, Weinberg RB, Schoenberg L, et al. Lipid abnormalities in renal transplant recipients treated with cyclo sporine.transplant Proc, 1989, 21:3 670
8 Pirsch J, D'Alessandro AM, Sollinger HW, et al. Hyperlipidemia and transplantation:etiologic factors and therapy.J Am Soc Neph rol, 1992, 2:238
9 Steinberg D, Parthasarathy S, Carew T E, et al. Beyond cholesterol, modification of low-density lipoprotein that inc reases its aThe rog enicity.N Eng1 J Med, 1989, 320:915
10 Apanay DC, Neylan JF, Ragab MS, et al.Cyclosporine incre ases The oxidizability of low-dnsity lipoprotein in renal transplant recipients.transplantation, 1994, 58:6 63 |
